Cancer treatment is entering a new era, driven by advances in precision medicine, AI, and targeted therapies known as theranostics. In this episode of Today in Tech, Keith Shaw speaks with Douglas ...

Memorial Şişli Hospital’s Nuclear Oncology and Theranostics Unit delivers advanced diagnostic and radioactive therapies for ...

Hear directly from local medical professionals as they discuss prostate cancer and treatments. Hear directly from local medical professionals as they discuss prostate cancer and treatments right here ...

“We are very appreciative of the entire team at Cyclotek for their support as we work together to bring an innovative new treatment option to patients battling prostate cancer.” RAD 402 has been ...

SYDNEY, Nov. 18, 2025 (GLOBE NEWSWIRE) -- Radiopharm Theranostics (ASX:RAD, “Radiopharm” or the “Company”), a clinical-stage biopharmaceutical company focused on developing innovative oncology ...

MELBOURNE, Australia and PALO ALTO, Calif., Dec. 10, 2025 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX, “Telix”) today announces a strategic clinical collaboration with ...

Veritas.AI is designed to advance the functionality of Spectrum Dynamics’ VERITON-CT scanner for nuclear imaging.

Interim results from Phase 2b clinical trial of RAD 101 showed 92% of evaluable participants met the primary endpoint of MRI concordance in ...

Patients with recurring prostate cancer who were treated with a new PSMA-targeted radioligand therapy before stereotactic body radiotherapy (SBRT) went more than twice as long without their disease ...

Memorial i li Hospital's Nuclear Oncology and Theranostics Unit delivers advanced diagnostic and radioactive therapies for prostate cancer, neuroendocrine tumors, and selected solid tumors within the ...